VASP

Vasodilator-stimulated phosphoprotein · P50552 · VASP on Sugi Atlas →

0 patent compounds predicted against VASP, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to VASP by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity PHASE4COMPLETED
Add-on Cangrelor in STEMI-triggered Cardiac Arrest PHASE4UNKNOWN
Effects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive Patients PHASE4COMPLETED
Influence of Nitrates on Bone Remodeling and Endothelial Function in Patients With Type 2 Diabetes Mellitus PHASE4WITHDRAWN
Methylene Blue and Microcirculation in Septic Shock PHASE3UNKNOWN
Use of Sildenafil Citrate in Management of Mild Pre-eclampsia PHASE2/PHASE3UNKNOWN
Trimetazidine as an Adjunct to Enhance Clopidogrel Response. PHASE2COMPLETED
Safety Study of Sildenafil in Treatment of Cerebral Aneurysm Vasospasm PHASE2WITHDRAWN
STRETCH Study: Effect of Distensibility on Endothelial-Dependent Vasoreactivity in Patients With ISH PHASE2COMPLETED
A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin on Subarachnoid Hemorrhage-Induced Vasospasm PHASE1/PHASE2COMPLETED
Perfusion by Arterial Spin Labelling Following Single Dose Tadalafil in Small Vessel Disease (PASTIS) Trial PHASE2COMPLETED
Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG) PHASE1RECRUITING
Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers PHASE1COMPLETED
Evaluating MED2005 & Nitrostat Bioavailability PHASE1COMPLETED
: Vascular Function in Health and Disease PHASE1RECRUITING
Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease PHASE1RECRUITING
C1q/TNF-related Protein 9 (CTRP 9) Level in Preeclamptic Obese and Non-obese Pregnancies nanCOMPLETED
Variability in Adrenergic Response nanCOMPLETED
AKI Cardiosurgery Diagnostic Study (AKI-CDS) nanUNKNOWN
Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms nanCOMPLETED
Intravenous Terbutaline in Severe Status Asthmaticus nanUNKNOWN
Identification of Novel Molecular Markers for Vasospasm nanCOMPLETED
Thrombin Regulated Platelet Activation nanCOMPLETED
Substance P-Induced Migraine Attacks Without Aura nanRECRUITING
iCorMicA - Stratified Medicine in Angina nanRECRUITING
The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) in Episodic Migraine Patients nanCOMPLETED
Role of Nitric Oxide in Diabetic Patients With Erectile Dysfunction nanCOMPLETED
StratosPHere (Non-interventional Study) nanCOMPLETED
Assessment of Disease Severity, Progression and Treatment in Infected Patients Presenting to the Emergency Department nanCOMPLETED
PACAP Induced Migraine Attacks in Patients With High and Low Genetic Load nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a VASP binder may also engage these)

ProteinNameSimilarity
P50551 1.000 P50551 →
Q2TA49 1.000 Q2TA49 →
P70460 1.000 P70460 →
O08719 0.995 O08719 →
P70429 0.993 P70429 →
Q9UI08 0.993 Q9UI08 →
Q5R896 0.992 Q5R896 →
P42768 0.987 P42768 →
Q8N8S7 0.986 Q8N8S7 →
O88339 0.982 O88339 →
P70315 0.981 P70315 →
O75061 0.981 O75061 →
Q27974 0.981 Q27974 →
Q7Z5R6 0.981 Q7Z5R6 →
EPN1 Epsin-1 0.980 landscape →
Q8CHU3 0.980 Q8CHU3 →
Q6P756 0.979 Q6P756 →
Q9Z1Z3 0.979 Q9Z1Z3 →
Q80VP1 0.979 Q80VP1 →
Q8IWZ8 0.978 Q8IWZ8 →
Q28E45 0.978 Q28E45 →
Q8VDD8 0.978 Q8VDD8 →
Q5TJ65 0.978 Q5TJ65 →
P36202 0.978 P36202 →
Q95107 0.978 Q95107 →
Q5EAW4 0.978 Q5EAW4 →
Q8VD37 0.977 Q8VD37 →
Q29M42 0.977 Q29M42 →
Q99KN9 0.977 Q99KN9 →
A7Z063 0.977 A7Z063 →